-+ 0.00%
-+ 0.00%
-+ 0.00%

Bio-Techne opens Bristol GMP small-molecule manufacturing facility to expand cell therapy supply network

PUBT·10/08/2026 12:03:03
Listen to the news
Bio-Techne opens Bristol GMP small-molecule manufacturing facility to expand cell therapy supply network
  • Bio-Techne opened a new GMP small-molecule manufacturing facility in Bristol, UK, expanding capacity for cell therapy supply chains.
  • The 10,000-square-foot site includes five ISO-8 cleanrooms, two ISO-7 cleanrooms, targeting scalable, reproducible production.
  • The Bristol buildout extends its GMP network alongside St. Paul, Minnesota, operations, supporting customers from development through commercial manufacturing.
  • The facility is operational, producing GMP-grade small molecules for cell therapy developers globally.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG63885) on October 08, 2026, and is solely responsible for the information contained therein.